Cat.No. | Name | Information |
---|---|---|
M4808 | TRV130 hydrochloride | TRV130 (Oliceridine) hydrochloride is a novel μ-opioid receptor (MOR) G protein-biased ligand. |
M1579 | Naloxone | Naloxone is an opioid inverse agonist drug used to counter the effects of opiate overdose. |
M9615 | DAMGO | DAMGO is an opioid receptor agonist with the ability to affect the locomotive activity in rodents, Kd value is 3.46 nM for native μ-OPR. |
M10432 | Difelikefalin (CR-845; FE-202845) TFA | Difelikefalin (CR-845; FE-202845) TFA is a synthetic peptide and the first-in-class, peripherally-restricted, selective agonist of the κ-opioid receptor (KOR) for studies related to pruritus. |
M10240 | CTOP TFA | CTOP TFA is a peptide that acts as a potent and selective μ opioid receptor antagonist, with Ki values of 0.96 and >10,000 nM for μ and δ receptors, respectively. |
M10229 | Porcine dynorphin A (1-13) | Porcine dynorphin A (1-13) is a potent, endogenous κ opioid receptor agonist. |
M9784 | Naloxegol oxalate | Naloxegol oxalate (NKTR-118 oxalate; AZ-13337019 oxalate) is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation. |
M9514 | JDTic | JDTic is a kappa opioid receptor (KOR) antagonist that prevents stress-induced reinstatement of cocaine-maintained responding and has antidepressant-like effects. |
M9268 | Met-Enkephalin | Met-Enkephalin (H-Tyr-Gly-Gly-Phe-Met-OH) inhibits tumor growth via binding to the opioid receptor. |
M8502 | Alvimopan | Alvimopan is a gastroprokinetic peripheral mu-opioid receptor antagonist. |
M6036 | Trimebutine maleate | Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects. |
M6035 | Trimebutine | Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain. |
M5589 | Docusate Sodium | Docusate Sodium is a compound used to study constipation. |
M5403 | Alvimopan dihydrate | Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). |
M5289 | PZM21 | PZM21 is a potent and selective μ-opioid-receptor (μOR) agonist with an EC50 of 1.8 nM. |
M5067 | Eluxadoline | Eluxadoline is an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist. |
M5065 | Cebranopadol | Cebranopadol is a NOP and opioid receptor agonist that acts on human NOP, MOP, KOP and δ-opioid peptide (DOP) receptors with Ki/EC50 values of 0.9 nM/13 nM and 0.7 nM/1.2 nM, respectively. 2.6 nM/17 nM, 18 nM/110 nM. |
M4456 | Sec-O-Glucosylhamaudol | Sec-o-glucosylhamaudol is a natural product isolated from The apostrophophore, which can reduce the protein level of μ-opioid receptor and can be used for pain relief research. |
M3240 | MCOPPB trihydrochloride | MCOPPB trihydrochloride is a trihydrochloride form of MCOPPB that is a new nonpeptide nociceptin/orphanin FQ peptide (NOP)-receptor agonist with a pKi of 10.07 ±0.01 for the human NOP recepto |
M2876 | Naloxone hydrochloride | Naloxone hydrochloride is an opioid inverse agonist compound used to counter the effects of opiate overdose. |
M2875 | Nalmefene hydrochloride | Nalmefene is an opioid receptor antagonist, it is used primarily in the management of alcohol dependence. |
M2838 | Meptazinol hydrochloride | Meptazinol is a unique centrally active opioid analgesic, which inhibits [3H]dihydromorphine binding with IC50 of 58 nM. |
M2214 | JTC-801 | JTC-801 is a novel opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.